182 related articles for article (PubMed ID: 15995848)
41. Sensitivity of serum insulin concentrations to glucagon-like peptide 1 (7-36)amide in sheep.
Faulkner A
Biochem Soc Trans; 1991 Aug; 19(3):311S. PubMed ID: 1783147
[No Abstract] [Full Text] [Related]
42. ERK and beyond: insights from B-Raf and Raf-1 conditional knockouts.
Galabova-Kovacs G; Kolbus A; Matzen D; Meissl K; Piazzolla D; Rubiolo C; Steinitz K; Baccarini M
Cell Cycle; 2006 Jul; 5(14):1514-8. PubMed ID: 16861903
[TBL] [Abstract][Full Text] [Related]
43. The importance of Raf dimerization in cell signaling.
Freeman AK; Ritt DA; Morrison DK
Small GTPases; 2013; 4(3):180-5. PubMed ID: 23985533
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast growth factor-2 suppresses oridonin-induced L929 apoptosis through extracellular signal-regulated kinase-dependent and phosphatidylinositol 3-kinase-independent pathway.
Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2006 Nov; 102(3):305-13. PubMed ID: 17116975
[TBL] [Abstract][Full Text] [Related]
45. Hyperglycemia and hyperinsulinemia have additive effects on activation and proliferation of pancreatic stellate cells: possible explanation of islet-specific fibrosis in type 2 diabetes mellitus.
Hong OK; Lee SH; Rhee M; Ko SH; Cho JH; Choi YH; Song KH; Son HY; Yoon KH
J Cell Biochem; 2007 Jun; 101(3):665-75. PubMed ID: 17212361
[TBL] [Abstract][Full Text] [Related]
46. On the effects of glucagon-like peptide-1 on blood glucose regulation in normal and diabetic subjects.
Holst JJ; Toft-Nielsen MB; Orskov C; Nauck M; Willms B
Ann N Y Acad Sci; 1996 Dec; 805():729-36. PubMed ID: 8993469
[No Abstract] [Full Text] [Related]
47. Targets of Raf in tumorigenesis.
Niault TS; Baccarini M
Carcinogenesis; 2010 Jul; 31(7):1165-74. PubMed ID: 20047953
[TBL] [Abstract][Full Text] [Related]
48. RAS/RAF/MEK inhibitors in oncology.
Rusconi P; Caiola E; Broggini M
Curr Med Chem; 2012; 19(8):1164-76. PubMed ID: 22257058
[TBL] [Abstract][Full Text] [Related]
49. Atorvastatin inhibits insulin synthesis by inhibiting the Ras/Raf/ERK/CREB pathway in INS-1 cells.
Sun H; Li Y; Sun B; Hou N; Yang J; Zheng M; Xu J; Wang J; Zhang Y; Zeng X; Shan C; Chang B; Chen L; Chang B
Medicine (Baltimore); 2016 Sep; 95(39):e4906. PubMed ID: 27684825
[TBL] [Abstract][Full Text] [Related]
50. Regulation of the pdx1 gene promoter in pancreatic beta-cells.
Campbell SC; Macfarlane WM
Biochem Biophys Res Commun; 2002 Nov; 299(2):277-84. PubMed ID: 12437983
[TBL] [Abstract][Full Text] [Related]
51. Ras-Mediated Activation of the Raf Family Kinases.
Terrell EM; Morrison DK
Cold Spring Harb Perspect Med; 2019 Jan; 9(1):. PubMed ID: 29358316
[TBL] [Abstract][Full Text] [Related]
52. K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.
Singh K; Deshpande P; Li G; Yu M; Pryshchep S; Cavanagh M; Weyand CM; Goronzy JJ
Proc Natl Acad Sci U S A; 2012 Jun; 109(25):E1629-37. PubMed ID: 22615393
[TBL] [Abstract][Full Text] [Related]
53. The role of Raf kinases in malignant transformation.
Kolch W; Kotwaliwale A; Vass K; Janosch P
Expert Rev Mol Med; 2002 Apr; 4(8):1-18. PubMed ID: 14987392
[TBL] [Abstract][Full Text] [Related]
54. Evidence that Ca2+ within the microdomain of the L-type voltage gated Ca2+ channel activates ERK in MIN6 cells in response to glucagon-like peptide-1.
Selway J; Rigatti R; Storey N; Lu J; Willars GB; Herbert TP
PLoS One; 2012; 7(3):e33004. PubMed ID: 22412973
[TBL] [Abstract][Full Text] [Related]
55. Development of small-molecule inhibitors of Raf.
Wu S; Guo W; Fang B
Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):241-6. PubMed ID: 18221149
[TBL] [Abstract][Full Text] [Related]
56. Leptin downregulates expression of the gene encoding glucagon in alphaTC1-9 cells and mouse islets.
Marroquí L; Vieira E; Gonzalez A; Nadal A; Quesada I
Diabetologia; 2011 Apr; 54(4):843-51. PubMed ID: 21234744
[TBL] [Abstract][Full Text] [Related]
57. Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics.
Yap JL; Worlikar S; MacKerell AD; Shapiro P; Fletcher S
ChemMedChem; 2011 Jan; 6(1):38-48. PubMed ID: 21110380
[No Abstract] [Full Text] [Related]
58. Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling.
Freeman AK; Ritt DA; Morrison DK
Mol Cell; 2013 Feb; 49(4):751-8. PubMed ID: 23352452
[TBL] [Abstract][Full Text] [Related]
59. How does glucagon-like peptide 1 stimulate human β-cell proliferation? A lesson from islet graft experiments.
Fujitani Y
J Diabetes Investig; 2018 Nov; 9(6):1255-1257. PubMed ID: 29770600
[TBL] [Abstract][Full Text] [Related]
60. Vasoactive intestinal peptide stimulates proliferation in HT29 human colonic adenocarcinoma cells: concomitant activation of Ras/Rap1-B-Raf-ERK signalling pathway.
Alleaume C; Eychène A; Caigneaux E; Muller JM; Philippe M
Neuropeptides; 2003 Apr; 37(2):98-104. PubMed ID: 12747941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
